Literature DB >> 24906607

Incidence and predictors of atrial fibrillation and its impact on long-term survival in patients with supraventricular arrhythmias.

Cevher Ozcan1, Jordan B Strom2, John B Newell2, Moussa C Mansour2, Jeremy N Ruskin3.   

Abstract

AIMS: To determine the incidence and predictors of atrial fibrillation (AF) and its impact on survival in patients with other forms of supraventricular arrhythmias (SVAs) including atrial flutter (AFL), atrial tachycardia (AT), atrioventricular reentrant (AVRT), and AV nodal reentrant tachycardia (AVNRT). We hypothesized that SVA may increase risk of AF and concomitant AF may influence long-term survival. METHODS AND
RESULTS: All patients who underwent catheter ablation for SVA from 2000 to 2010 were included in this study. The patients were identified retrospectively and the vital status determined prospectively. Observed survival in the study cohort was compared with survival rates in the age- and sex-matched general population. The study group included 1573 patients (mean age 50.5 ± 18 years, 47% female) with AVNRT (38.5%), AFL (29.6%), AVRT (22.6%) and AT (9.3%). The patients were followed for a mean of 35 months (median 23 months). Atrial fibrillation was documented in 424 patients (27%) with a higher incidence in males (35 vs. 18%). Atrial fibrillation was present in 19.6% of patients before the ablation and developed in 9.07% after ablation. Atrial fibrillation commonly occurred in patients with AFL (57.5%), AT (27.4%), AVRT (13.5%), and AVNRT (9.7%). Older age, prolonged PR interval, dilated left atrium, low left ventricular ejection fraction and presence of AFL were independent predictors for concomitant AF. Long-term survival was worse in the presence of AF.
CONCLUSION: The incidence of AF is high in patients with other forms of SVA. The most common association is between AFL and AF. Long-term survival is decreased in those who have concomitant AF, although AF did not emerge as an independent predictor of mortality when adjusted for other covariates. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2014. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Ablation; Atrial fibrillation; Predictors; Supraventricular tachycardia; Survival

Mesh:

Year:  2014        PMID: 24906607     DOI: 10.1093/europace/euu129

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  8 in total

Review 1.  European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS).

Authors:  Bulent Gorenek; Antonio Pelliccia; Emelia J Benjamin; Giuseppe Boriani; Harry J Crijns; Richard I Fogel; Isabelle C Van Gelder; Martin Halle; Gulmira Kudaiberdieva; Deirdre A Lane; Torben Bjerregaard Larsen; Gregory Y H Lip; Maja-Lisa Løchen; Francisco Marin; Josef Niebauer; Prashanthan Sanders; Lale Tokgozoglu; Marc A Vos; David R Van Wagoner; Laurent Fauchier; Irina Savelieva; Andreas Goette; Stefan Agewall; Chern-En Chiang; Márcio Figueiredo; Martin Stiles; Timm Dickfeld; Kristen Patton; Massimo Piepoli; Ugo Corra; Pedro Manuel Marques-Vidal; Pompilio Faggiano; Jean-Paul Schmid; Ana Abreu
Journal:  Eur J Prev Cardiol       Date:  2016-11-04       Impact factor: 7.804

Review 2.  European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS).

Authors:  Bulent Gorenek; Antonio Pelliccia; Emelia J Benjamin; Giuseppe Boriani; Harry J Crijns; Richard I Fogel; Isabelle C Van Gelder; Martin Halle; Gulmira Kudaiberdieva; Deirdre A Lane; Torben Bjerregaard Larsen; Gregory Y H Lip; Maja-Lisa Løchen; Francisco Marín; Josef Niebauer; Prashanthan Sanders; Lale Tokgozoglu; Marc A Vos; David R Van Wagoner; Laurent Fauchier; Irina Savelieva; Andreas Goette; Stefan Agewall; Chern-En Chiang; Márcio Figueiredo; Martin Stiles; Timm Dickfeld; Kristen Patton; Massimo Piepoli; Ugo Corra; Pedro Manuel Marques-Vidal; Pompilio Faggiano; Jean-Paul Schmid; Ana Abreu
Journal:  Europace       Date:  2017-02-01       Impact factor: 5.214

3.  Optimum Risk Assessment for Stroke in Atrial Fibrillation: Should We Hold the Status Quo or Consider Magnitude Synergism and Left Atrial Appendage Anatomy?

Authors:  James A Reiffel
Journal:  Arrhythm Electrophysiol Rev       Date:  2017-12

4.  Molecular Mechanism of the Association Between Atrial Fibrillation and Heart Failure Includes Energy Metabolic Dysregulation Due to Mitochondrial Dysfunction.

Authors:  Cevher Ozcan; Zhenping Li; Gene Kim; Valluvan Jeevanandam; Nir Uriel
Journal:  J Card Fail       Date:  2019-08-12       Impact factor: 5.712

5.  The relationship between coronary microvascular dysfunction, atrial fibrillation and heart failure with preserved ejection fraction.

Authors:  Cevher Ozcan; Tess Allan; Stephanie A Besser; Anthony de la Pena; John Blair
Journal:  Am J Cardiovasc Dis       Date:  2021-02-15

6.  LKB1 knockout mouse develops spontaneous atrial fibrillation and provides mechanistic insights into human disease process.

Authors:  Cevher Ozcan; Emily Battaglia; Rebeccah Young; Gen Suzuki
Journal:  J Am Heart Assoc       Date:  2015-03-15       Impact factor: 5.501

7.  Redox and Activation of Protein Kinase A Dysregulates Calcium Homeostasis in Pulmonary Vein Cardiomyocytes of Chronic Kidney Disease.

Authors:  Shih-Yu Huang; Yao-Chang Chen; Yu-Hsun Kao; Ming-Hsiung Hsieh; Yung-Kuo Lin; Shih-Ann Chen; Yi-Jen Chen
Journal:  J Am Heart Assoc       Date:  2017-07-12       Impact factor: 5.501

8.  An unusual cause of lone atrial fibrillation in a young female subject due to a rapid-cycling focal atrial trigger.

Authors:  Shankar Baskar; Mehran Attari; Richard J Czosek; Pierre Jais; Jeffrey B Anderson; David S Spar
Journal:  HeartRhythm Case Rep       Date:  2018-04-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.